CoChat

Human umbilical cord mesenchymal stem cells combined with pirfenidone upregulates the expression of RGS2 in the pulmonary fibrosis in mice

Open access
Wu, Xian, Gou, Hao, Zhou, Ou, Qiu, Huijun, Liu, Hanmin, Fu, Zhou, Chen, Lina · 2022 · Respiratory Research

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Objective: The therapeutic effect of umbilical cord-derived mesenchymal stem cells (hUC-MSCs) in combination with pirfenidone (PFD) on pulmonary fibrosis in mice and its possible mechanism were investigated. Methods: C57BL/6 mice were randomly divided into six groups: control group, model group, P 10 group, P 30 group, P 100 group, and P 300 group. Modeled by tracheal intubation with 3 mg/kg bleomycin drip, each dose of PFD was administered daily by gavage from day 7 onwards. The mice were observed continuously for 21 days and survival was recorded. Lung tissues were collected on day 21, and hematoxylin–eosin (HE) and Masson staining were performed to assess morphological changes and collagen deposition in the lungs. Collagen content was measured by the Sircol method, and fibrosis marker levels were detected by PCR and Western blot. Another batch of C57BL/6 mice was then randomly divided into five groups: hUC-MSC control group, model group, P 100 group, hUC-MSC treatment group, and hUC-MSCs + P 30 group. On day 7, 5 × 10 5 hUC-MSCs were injected into the tail vein, the mice were administered PFD gavage daily from day 7 onwards, and their survival was recorded. Lung tissues were collected on day 21 to detect pathological changes, the collagen content, and the expression of regulator of G protein signaling 2 (RGS2). Pulmonary myofibroblasts (MFBs) were divided into an MFB group and an MFB + hUC-MSCs group; different doses of PFD were administered to each group, and the levels of RGS2, intracellular Ca 2+, and fibrosis markers were recorded for each group. Results: Compared with other PFD group doses, the P 100 group had significantly improved mouse survival and lung pathology and significantly reduced collagen and fibrosis marker levels (p < 0.05). The hUC-MSCs + P 30 group had significantly improved mouse survival and lung pathology, significantly reduced collagen content and fibrosis marker levels (p < 0.05), and the efficacy was better than that of the P 100 and hUC-MSCs groups (p < 0.05). RGS2 expression was significantly higher in the MSCs + P 30 group compared with the P 100 and hUC-MSCs groups (p < 0.05). PFD increased RGS2 expression in MFBs (p < 0.05) in a dose-dependent manner. Compared with PFD and hUC-MSCs treatment alone, combination of hUC-MSCs and PFD increased RGS2 protein levels, significantly decreased intracellular Ca 2+ concentration, and significantly reduced fibrosis markers. Conclusion: The findings suggest that hUC-MSCs combined with low-dose PFD have a therapeutic effect better than that of the two treatments used separately. Its effect on attenuating bleomycin-induced pulmonary fibrosis in mice is related to the increase of RGS2.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12931-022-02192-6

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Therapeutic effects of different doses of PFD in bleomycin (BLM)-induced pulmonary fibrosis in mice. A The Kaplan–Meier survival curves of different doses of PFD groups (n = 10 each group). B The total soluble collagen content in the right lungs of different groups of mice (μg/right lung) (n = 10). C, E Representative pictures of hematoxylin–eosin (HE) and Masson staining of lung sections of different groups of pulmonary fibrosis mice. Scale bars: 200 μm. D, F The Ashcroft score of HE and Masson staining of different groups of pulmonary fibrosis mice (n = 3–4). G, H, I The mRNA levels of main pulmonary fibrosis markers (Col1a1, Col1a2, and α-SMA) of different groups of mice. Values are means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.01
Fig. 1 Therapeutic effects of different doses of PFD in bleomycin (BLM)-induced pulmonary fibrosis in mice. A The Kaplan–Meier survival curves of different doses of PFD groups (n = 10 each group). B The total soluble collagen content in the right lungs of different groups of mice (μg/right lung) (n = 10). C, E Representative pictures of hematoxylin–eosin (HE) and Masson staining of lung sections of different groups of pulmonary fibrosis mice. Scale bars: 200 μm. D, F The Ashcroft score of HE and Masson staining of different groups of pulmonary fibrosis mice (n = 3–4). G, H, I The mRNA levels of main pulmonary fibrosis markers (Col1a1, Col1a2, and α-SMA) of different groups of mice. Values are means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.01CC BY · PubMed Central
Fig. 2 The pluripotency of hUC-MSCs. A The expression of the surface markers CD34, CD45, HLA-DR, CD73, CD90, and CD105 in hUC-MSCs detected by flow cytometry. B, C, D The results of hUC-MSC differentiation into chondrocytes, osteocytes, and adipocytes. B Alcian blue staining of hUC-MSCs after 24-day culture. C Alizarin red staining of hUC-MSCs after 20-day culture. D Oil Red O staining of hUC-MSCs after 15-day culture
Fig. 2 The pluripotency of hUC-MSCs. A The expression of the surface markers CD34, CD45, HLA-DR, CD73, CD90, and CD105 in hUC-MSCs detected by flow cytometry. B, C, D The results of hUC-MSC differentiation into chondrocytes, osteocytes, and adipocytes. B Alcian blue staining of hUC-MSCs after 24-day culture. C Alizarin red staining of hUC-MSCs after 20-day culture. D Oil Red O staining of hUC-MSCs after 15-day cultureCC BY · PubMed Central
Fig. 3 Therapeutic effects of hUC-MSCs combined with P30 in BLM-induced pulmonary fibrosis in mice. A The Kaplan–Meier survival curves of different groups (n = 10). B The total soluble collagen content in the right lungs of different groups of mice (μg/right lung) (n = 10). C, E Representative pictures of HE and Masson staining of lung sections of different groups of pulmonary fibrosis mice. Scale bars: 200 μm. D, F The Ashcroft score of HE and Masson staining of different groups (n = 4). G, H, I The mRNA levels of main pulmonary fibrosis markers (Col1a1, Col1a2, and α-SMA) in different groups of pulmonary fibrosis mice. Values are means ± SEM (n = 3).*p < 0.05; **p < 0.01;***p < 0.01
Fig. 3 Therapeutic effects of hUC-MSCs combined with P30 in BLM-induced pulmonary fibrosis in mice. A The Kaplan–Meier survival curves of different groups (n = 10). B The total soluble collagen content in the right lungs of different groups of mice (μg/right lung) (n = 10). C, E Representative pictures of HE and Masson staining of lung sections of different groups of pulmonary fibrosis mice. Scale bars: 200 μm. D, F The Ashcroft score of HE and Masson staining of different groups (n = 4). G, H, I The mRNA levels of main pulmonary fibrosis markers (Col1a1, Col1a2, and α-SMA) in different groups of pulmonary fibrosis mice. Values are means ± SEM (n = 3).*p < 0.05; **p < 0.01;***p < 0.01CC BY · PubMed Central
Fig. 4 The RGS2 mRNA and protein expression levels in mouse lung tissue and cells of different groups. A The RGS2 mRNA levels detected by RT-PCR in mouse lung tissue of different groups (n = 3). B The RGS2 protein expression levels detected by Western blot in mouse lung tissue of different groups (n = 3). C The results are expressed as a bar graph that illustrates RGS2 protein expression, measured as the RGS2/β-actin protein ratio of these groups. The results are presented as means ± SEM (n = 3). D, E HLF-9 (D) and NIH3T3 (E) were treated with various concentrations of PFD (0–10 mM) for 2 h and were then harvested for RT-PCR analysis of RGS2 and β-actin × 1000 mRNA levels. F, G HLF-9 (F) and NIH3T3 (G) were treated with 8 mM PFD over 24 h and were then harvested for RT-PCR analysis of fibrosis marker mRNA levels (n = 3). H Schematic diagram of single culture and co-culture of hUC-MSCs and MFBs. *p < 0.05; **p < 0.01; ***p < 0.01
Fig. 4 The RGS2 mRNA and protein expression levels in mouse lung tissue and cells of different groups. A The RGS2 mRNA levels detected by RT-PCR in mouse lung tissue of different groups (n = 3). B The RGS2 protein expression levels detected by Western blot in mouse lung tissue of different groups (n = 3). C The results are expressed as a bar graph that illustrates RGS2 protein expression, measured as the RGS2/β-actin protein ratio of these groups. The results are presented as means ± SEM (n = 3). D, E HLF-9 (D) and NIH3T3 (E) were treated with various concentrations of PFD (0–10 mM) for 2 h and were then harvested for RT-PCR analysis of RGS2 and β-actin × 1000 mRNA levels. F, G HLF-9 (F) and NIH3T3 (G) were treated with 8 mM PFD over 24 h and were then harvested for RT-PCR analysis of fibrosis marker mRNA levels (n = 3). H Schematic diagram of single culture and co-culture of hUC-MSCs and MFBs. *p < 0.05; **p < 0.01; ***p < 0.01CC BY · PubMed Central
Fig. 5 RGS2 suppresses the profibrotic effects in HLF-9 and NIH3T3. A, E HLF-9 (A) and NIH3T3 (E) were single cultured or co-cultured with hUC-MSCs 24 h after adding 4 ng/mL TGF-β1, treated with 8 mM PFD or an equal amount of PBS buffer for 2 h, and were then harvested for RT-PCR analysis of RGS2 and β-actin mRNA levels. Values are means ± SEM (n = 3). B, F RGS2 protein expression levels detected by Western blot in HLF-9 (B) and NIH3T3 (E) treated with hUC-MSCs and/or PFD. C, G RGS2 protein expression measured as the RGS2/β-actin protein ratio in HLF-9 (C) and NIH3T3 (G) treated with hUC-MSCs and/or PFD. Densities of bands were quantified using the ImageJ program. The results are presented as means ± SEM (n = 3). D, H HLF-9 and NIH3T3 cells were treated with TGF-β1 (4 ng/ml) firstly. Then, the Fluo-3 fluorescence of intracellular Ca2+ level in HLF-9 (D) and NIH3T3 (H) cells treated with PFD and/or hUC-MSCs were measured. The cells were excited at 488 nm and Ca2+-bound Fluo-3 emission was recorded at 530 nm. The Fluo-3 fluorescence from three separate exeachiments was plotted as means ± SEM. I, J HLF-9 (I) and NIH3T3 (J) were single cultured or co-cultured with hUC-MSCs, treated with 8 mM PFD for 24 h, and were then harvested for RT-PCR analysis of fibrosis marker mRNA levels. Values are means ± SEM (n = 3). K hUC-MSCs were treated with 4 ng/ml TGF-β1 and cultured for 24 h, treated with 8 mM PFD or an equal amount of PBS buffer for 24 h, and were then harvested for RT-PCR analysis of E-cad, FN, α-SMA mRNA levels. Values are means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.01
Fig. 5 RGS2 suppresses the profibrotic effects in HLF-9 and NIH3T3. A, E HLF-9 (A) and NIH3T3 (E) were single cultured or co-cultured with hUC-MSCs 24 h after adding 4 ng/mL TGF-β1, treated with 8 mM PFD or an equal amount of PBS buffer for 2 h, and were then harvested for RT-PCR analysis of RGS2 and β-actin mRNA levels. Values are means ± SEM (n = 3). B, F RGS2 protein expression levels detected by Western blot in HLF-9 (B) and NIH3T3 (E) treated with hUC-MSCs and/or PFD. C, G RGS2 protein expression measured as the RGS2/β-actin protein ratio in HLF-9 (C) and NIH3T3 (G) treated with hUC-MSCs and/or PFD. Densities of bands were quantified using the ImageJ program. The results are presented as means ± SEM (n = 3). D, H HLF-9 and NIH3T3 cells were treated with TGF-β1 (4 ng/ml) firstly. Then, the Fluo-3 fluorescence of intracellular Ca2+ level in HLF-9 (D) and NIH3T3 (H) cells treated with PFD and/or hUC-MSCs were measured. The cells were excited at 488 nm and Ca2+-bound Fluo-3 emission was recorded at 530 nm. The Fluo-3 fluorescence from three separate exeachiments was plotted as means ± SEM. I, J HLF-9 (I) and NIH3T3 (J) were single cultured or co-cultured with hUC-MSCs, treated with 8 mM PFD for 24 h, and were then harvested for RT-PCR analysis of fibrosis marker mRNA levels. Values are means ± SEM (n = 3). K hUC-MSCs were treated with 4 ng/ml TGF-β1 and cultured for 24 h, treated with 8 mM PFD or an equal amount of PBS buffer for 24 h, and were then harvested for RT-PCR analysis of E-cad, FN, α-SMA mRNA levels. Values are means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.01CC BY · PubMed Central
Fig. 6 A Representative images of NIH3T3 transfected with or without siRNA. B The number of NIH3T3 in RGS2-siRNA-transfected and control groups (n = 3). C Top: Representative Western blot of RGS2 protein expression in Rgs2-siRNA-transfected groups and control groups of NIH3T3. Bottom: The results are expressed as a bar graph that illustrates RGS2 protein level of Western blot, measured as the RGS2/β-actin protein ratio. The results are presented as means ± SEM (n = 3). D The level of RGS2 mRNA was evaluated by RT-PCR presented as means ± SEM (n = 3). F, G, H The mRNA levels of main pulmonary fibrosis markers (Col1a1, Col1a2, and α-SMA) in Rgs2-siRNA-transfected groups and control groups of NIH3T3 without or with PFD or/and hUC-MSCs treatment. Values are means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.01
Fig. 6 A Representative images of NIH3T3 transfected with or without siRNA. B The number of NIH3T3 in RGS2-siRNA-transfected and control groups (n = 3). C Top: Representative Western blot of RGS2 protein expression in Rgs2-siRNA-transfected groups and control groups of NIH3T3. Bottom: The results are expressed as a bar graph that illustrates RGS2 protein level of Western blot, measured as the RGS2/β-actin protein ratio. The results are presented as means ± SEM (n = 3). D The level of RGS2 mRNA was evaluated by RT-PCR presented as means ± SEM (n = 3). F, G, H The mRNA levels of main pulmonary fibrosis markers (Col1a1, Col1a2, and α-SMA) in Rgs2-siRNA-transfected groups and control groups of NIH3T3 without or with PFD or/and hUC-MSCs treatment. Values are means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.01CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 2

  1. Oku H, Shimizu T, Kawabata T, Nagira M, Hikita I, Ueyama A, et al. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced pulmonary fibrosis. Eur J Pharmacol. 2008;20:400–8. · DOI · Paper page
  2. Zhao H, Li CD, Li LN, Liu JY, Gao YH, Mu K. Baicalin alleviates bleomycin-induced pulmonary fibrosis and fibroblast proliferation in rats via the PI3K/AKT signaling pathway. Mol Med Rep. 2020;21(6):2321–34.

Cited by

See all 11

Metadata

Authors
Wu, X., Gou, H., Zhou, O., Qiu, H., Liu, H., Fu, Z., & Chen, L.
Affiliations
  • Sichuan University (CN)
  • Chengdu University of Traditional Chinese Medicine (CN)
  • Children's Hospital of Chongqing Medical University (CN)
Corresponding author
  • Fu, Zhou
  • Chen, Lina
Venue
Respiratory Research
Published
2022-10-01
Volume
23
Issue
1
Pages
270-270
ISSN
  • 1465-9921 (ISSN-L)
  • 1465-993X
OpenAlex
W4298615123
Cited by
11
References
49
Citations by year
2026: 3 · 2025: 3 · 2024: 2 · 2023: 3
FWCI
1.29
Type
journal article
Language
en
Open access
Licence
Locations
  • Respiratory Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (NSFC 81670018)
  • Key project from Chinese Ministry of Science and Technology (2016YFA0101300)
  • Science & Technology department of Sichuan Province (22ZDZX0014 and 2020YFS0105)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
Keywords
human umbilical cord mesenchymal stem cells, pirfenidone, pulmonary fibrosis, RGS2, myofibroblasts, bleomycin-induced fibrosis, combination therapy, intracellular calcium, collagen deposition, fibrosis biomarkers, mouse model, survival, lung pathology, G protein signaling, antifibrotic agents
MeSH terms
Animals, Bleomycin, Eosine Yellowish-(YS), Fibrosis, Hematoxylin, Humans, Mice, Inbred C57BL, Pulmonary Fibrosis, Pyridones, Umbilical Cord, GTP-Binding Proteins, RGS Proteins, Mesenchymal Stem Cell Transplantation, Mice, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human umbilical cord mesenchymal stem cells combined with pirfenidone upregulates the expression of RGS2 in the pulmonary fibrosis in mice. https://app.cochat.ai/papers/10.1186/s12931-022-02192-6
The paper
Wu, X., Gou, H., Zhou, O., Qiu, H., Liu, H., Fu, Z., & Chen, L. (2022). Human umbilical cord mesenchymal stem cells combined with pirfenidone upregulates the expression of RGS2 in the pulmonary fibrosis in mice. Respiratory Research. https://doi.org/10.1186/s12931-022-02192-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.